InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Robbins Andrew R. Director active across 2 companies, notably Harpoon Therapeutics, Inc.. Aggregated, 5 disclosures have been logged. Activity tracked since 27 November 2023. The latest transaction was disclosed on 19 May 2026 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Robbins Andrew R is a declarant linked to 4 filings in total. The 4 sampled filings run from 2023-11-28 to 2026-05-21, with sum_buy_eur at 0 and sum_sell_eur at 0. He is associated with Cogent Biosciences, Inc., where his listed role is President and CEO, and with Harpoon Therapeutics, Inc., where his listed role is Director.